STAAR Surgical (STAA) CFO logs RSU vesting and share dispositions
Rhea-AI Filing Summary
STAAR Surgical reports equity award activity for Chief Financial Officer & EVP Deborah J. Andrews. On June 25 and July 31, 2026, previously granted RSUs vested, converting into a total of 34742 shares of common stock. In related code F transactions, 6480 shares at $31.2100 and 10576 shares at $24.3600 per share were disposed of to pay exercise price or tax liability, with no open-market purchases or sales reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 17,686 shares
Net Buy
6 txns
Insider
ANDREWS DEBORAH J
Role
Chief Financial Officer & EVP
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2 | 20,787 | $0.00 | $0.00 |
| Exercise | Common Stock F2 | 20,787 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 10,576 | $24.36 | $258K |
| Exercise | Restricted Stock Units F1 | 13,955 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 13,955 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 6,480 | $31.21 | $202K |
Holdings After Transaction:
Restricted Stock Units — 27,912 shares (Direct);
Common Stock — 36,339 shares (Direct)
Footnotes (2)
- F1. Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis.
- F2. Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.
Key Figures
RSUs vested on June 25, 2026: 13955 shares
RSUs vested on July 31, 2026: 20787 shares
Total RSUs converted: 34742 shares
+3 more
6 metrics
RSUs vested on June 25, 2026
13955 shares
Restricted stock units converting one-for-one into common stock for CFO appointment grant
RSUs vested on July 31, 2026
20787 shares
Restricted stock units converting one-for-one into common stock for Interim Co-CEO grant
Total RSUs converted
34742 shares
Combined common shares issued upon RSU vesting on June 25 and July 31, 2026
Shares disposed at $31.2100
6480 shares
Code F disposition at $31.2100 per share in payment of exercise price or tax liability
Shares disposed at $24.3600
10576 shares
Code F disposition at $24.3600 per share in payment of exercise price or tax liability
Total code F shares
17056 shares
Aggregate shares delivered or withheld in code F transactions related to RSU vesting
Key Terms
Restricted Stock Units, one-for-one basis, tax liability, Interim Co-Chief Executive Officer
4 terms
Restricted Stock Units financial
"Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
one-for-one basis financial
"The RSUs convert into common stock on a one-for-one basis."
tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
Interim Co-Chief Executive Officer financial
"in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did STAAR Surgical (STAA) report for CFO Deborah Andrews?
STAAR Surgical reported RSU vesting for CFO Deborah Andrews on June 25 and July 31, 2026, converting 34742 shares of common stock, along with related code F dispositions where shares were delivered or withheld to pay exercise price or tax liability.
How many STAAR Surgical (STAA) RSUs vested for the CFO in June and July 2026?
Two RSU grants vested, converting into 13955 shares of common stock on June 25, 2026, and 20787 shares on July 31, 2026, for a combined total of 34742 shares issued upon vesting to CFO Deborah Andrews.
Were the STAAR Surgical (STAA) insider transactions open-market trades?
No. The filing shows no open-market purchases or sales; all activity relates to RSU vesting (code M) and code F dispositions, where shares were delivered or withheld to pay exercise price or tax liability rather than traded on the open market.
Why were RSUs granted to the STAAR Surgical (STAA) CFO and Interim Co-Chief Executive Officer?
One RSU grant was made on June 25, 2025 in connection with Deborah Andrews’ appointment as Chief Financial Officer, vesting one-third annually from 2026–2028. Another RSU grant on February 2, 2026 was tied to her appointment as Interim Co-Chief Executive Officer and vested on July 31, 2026.